Rakuten Medical Stock

rakuten-med.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $760.74MM

Rakuten Medical is a biotechnology company that strives to develop cancer treatments. Their approach involves the use of cell-targeting therapies that are administered through the company’s proprietary Alluminox platform. Rakuten Medical was founded in 2010 and is headquartered in San Diego, CA. The platform is based on a cancer therapy called photoimmunotherapy, which was developed by Dr. Hisataka Kobayashi and the team at the U.S.-based National Cancer Institute. The global company focuses on the development and commercialization of its precision-based therapies designed to treat a variety of cancers.

Register To Buy and Sell Shares

For more details on financing and valuation for Rakuten Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Rakuten Medical’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Rakuten Medical.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Rakuten Medical investors also invested in these private companies


Management Team

Takashi Toraishi Ph.D
President & Chief Operating Officer
Hiroshi Mikitani
Chief Executive Officer & Chairman
Miguel Garcia-Guzman Ph.D
Vice Chairman & CSO
Merrill Biel Ph.D
Chief Medical Officer
Carlos Garcia
Chief Technology Officer
Agatha Martindale
Vice President, Finance

Frequently Asked Questions About Rakuten Medical’s Stock

Can you buy Rakuten Medical’s stock?
Rakuten Medical is not publicly traded on NYSE or NASDAQ in the U.S. To buy Rakuten Medical’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Rakuten Medical’s stock?
Yes, you can sell stock of a private company like Rakuten Medical. Forge can help you sell your Rakuten Medical stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Rakuten Medical’s stock price?
Rakuten Medical is a privately held company and therefore does not have a public stock price. However, you may access Rakuten Medical’s private market stock price with Forge Data.
What is Rakuten Medical’s stock ticker symbol?
Rakuten Medical does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform
In a Series E funding round, Rakuten Medical closed new capital for its cell therapy.
Rakuten Medical Closes $166M in Series D Funding
Rakuten Medical, a San Mateo CA-based biotechnology company focused on developing and commercializing innovative oncology products for multiple indications, raised $166M in Series D funding
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.